Navigation Links
Johns Hopkins researchers capture jumping genes
Date:2/4/2011

An ambitious hunt by Johns Hopkins scientists for actively "jumping genes" in humans has yielded compelling new evidence that the genome, anything but static, contains numerous pesky mobile elements that may help to explain why people have such a variety of physical traits and disease risks.

Using bioinformatics to compare the standard assembly of genetic elements as outlined in the reference human genome to raw whole-genome data from 310 individuals recently made available by the 1000 Genomes Project, the team revealed 1,016 new insertions of RIPs, or retrotransposon insertion polymorphisms, thereby expanding the catalog of insertions that are present in some individuals and absent in others. Their results appeared online October 27 in Genome Research.

Retrotransposons are travelling bits of DNA that replicate by copying and pasting themselves at new locations in the genome. Having duplicated themselves and accumulated over evolutionary history, transposable elements now make up about half of the human genome. However, only a tiny subfamily of these insertions known as LINE-1 (L1) is still active in humans. Line 1 insertions are able to mobilize not only themselves but also other pieces of DNA.

"In any individual, only between 80 to 100 retrotransposons are actively copying and inserting into new sites," says Haig Kazazian, M.D., professor of human genetics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine. "We're not only discovering where they are and who has which ones, but also finding out that they insert with a remarkable frequency: On the order of one in every 50 individuals has a brand-new insertion that wasn't in their parents."

The researchers recognized L1 retrotransposons distinguishing them from the vast amount of fixed "fossil" transposable elements that litter the genome because these actively jumping genes are human specific and almost exactly the same in sequence from one person to another.

"Our genome contains around half a million interspersed L1 sequences that have accumulated over evolutionary history, along with over a million more repeats, most of which were mobilized by L1 elements," explains Adam D. Ewing, Ph.D., a postdoctoral fellow in Kazazian's lab. "Since the vast majority of these are ancestral and therefore common to all humans and even some of our primate relatives, we can ignore them and focus on L1s that contain human-specific characters in their sequences. Those are the actively mobilized elements responsible for considerable genomic diversity among human individuals."

The high frequency of these L1 insertions gives us a better idea about the extent of human diversity, according to Kazazian, whose 22-year focus on retrotransposons seeks to reveal how they alter the expression of human genes.

Just as the structural variants known as single nucleotide polymorphisms (or SNPs, pronounced "snips") serve as markers for various diseases, the hope is that RIPs which are up to 6,000 times bigger than SNPs, and therefore may have a stronger effect on gene expression will correlate with disease phenotypes.

"In that same way that someone had to go out and find the SNPs, this study was about finding RIPs that remain active and continue to produce new insertions," Kazazian says. "Now we have the background necessary to begin studies that may correlate these L1 insertions with everything from autism to cancer."


'/>"/>

Contact: Maryalice Yakutchik
myakutc1@jhmi.edu
443-287-2251
Johns Hopkins Medical Institutions
Source:Eurekalert

Related biology news :

1. Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk
2. Johns Hopkins scientists pull proteins tail to curtail cancer
3. Case Western Reserve University works with Johnson & Johnson Services Inc. on research grant
4. Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant awarded to Johns Hopkins Early Career investigator
5. Johns Hopkins scientists discover a controller of brain circuitry
6. JDRF announces diabetes research program with Johnson & Johnson
7. Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinsons
8. American Society for Microbiology honors Ryan Johnson
9. UNCs Dr. Sean McLean receives Robert Wood Johnson Foundation award
10. Johns Hopkins researchers reshape basic understanding of cell division
11. Encyclopedia of Life names Dr. Rebecca Johnson a 2011 Rubenstein Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):
(Date:5/18/2017)... ... May 18, 2017 , ... When James Sherley, was notified earlier this year that his company ... the Year 2017 by The Silicon Review , he was not surprised as others ... Asymmetrex’s value, but this recognition by Silicon Valley was particularly meaningful. Our selection ...
(Date:5/16/2017)... ... May 16, 2017 , ... ... general availability of its new ProxiMeta™ Hi-C metagenomic deconvolution service. ProxiMeta enables ... culturing or high-molecular-weight DNA extraction—speeding research insights at lower cost. , “We’re ...
(Date:5/16/2017)... ... May 16, 2017 , ... ... cancer diagnostics, has released its ClearID Lung Cancer blood test. Leveraging a highly-sensitive ... this new test is designed to quickly and accurately identify tumor-related genetic mutations ...
(Date:5/16/2017)... ... (PRWEB) May 16, 2017 , ... ... of Orthopaedic Surgeons (CAOS), long-standing development partners Invibio Biomaterial Solutions, UK, and ... surgery workshop to help expand knowledge of the implantation of Double Medical’s ...
Breaking Biology Technology: